Ajanta Pharma Limited 경쟁사
가격 내역 및 성능
| 과거 주가 | |
|---|---|
| 현재 주가 | ₹2,984.50 |
| 52주 최고치 | ₹3,485.00 |
| 52주 최저치 | ₹1,783.50 |
| 베타 | 0.087 |
| 11개월 변경 | -10.23% |
| 3개월 변경 사항 | 7.03% |
| 1년 변경 사항 | 64.22% |
| 33년 변화 | 104.92% |
| 5년 변화 | 353.48% |
| IPO 이후 변화 | 18,955.41% |
최근 뉴스 및 업데이트
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Oct 31
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Sep 10Recent updates
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Oct 31Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Sep 10We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Aug 23Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 04Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E
Aug 01With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case
Jun 01Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
May 05Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price
Apr 05We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Feb 23Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected
Dec 23Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Aug 26These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well
Feb 07Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Oct 24Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Aug 25Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?
Jul 19A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Apr 28Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Mar 14I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut
Feb 06Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Dec 13Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50
Oct 31Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching
Sep 22Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?
Sep 08Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?
Aug 26Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet
Jul 07Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?
Jun 14Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?
May 15Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 10Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Mar 11Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?
Feb 24The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On
Jan 30
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?
Jan 18Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Jan 06주주 수익률
| AJANTPHARM | IN Pharmaceuticals | IN 마켓 | |
|---|---|---|---|
| 7D | 2.1% | 2.0% | 1.8% |
| 1Y | 64.2% | 58.6% | 36.8% |
수익률 대 산업: AJANTPHARM exceeded the Indian Pharmaceuticals industry which returned 58.6% over the past year.
수익률 대 시장: AJANTPHARM exceeded the Indian Market which returned 36.8% over the past year.
가격 변동성
| AJANTPHARM volatility | |
|---|---|
| AJANTPHARM Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
안정적인 주가: AJANTPHARM has not had significant price volatility in the past 3 months compared to the Indian market.
시간에 따른 변동성: AJANTPHARM's weekly volatility (5%) has been stable over the past year.
회사 소개
| 설립 | 직원 | CEO | 웹사이트 |
|---|---|---|---|
| 1973 | 8,073 | Yogesh Agrawal | www.ajantapharma.com |
전문 의약품 제제 회사인 Ajanta Pharma Limited는 자회사와 함께 전문 의약품 완제의약품을 개발, 제조 및 판매합니다. 이 회사는 심장학, 항당뇨, 안과, 피부과, 통증 관리, 호흡기 분야 등 다양한 치료 분야를 마케팅하고 서비스를 제공합니다. 또한 정제, 캡슐, 주사제, 흡입기, 연고, 크림, 액상 제품도 제공합니다.
Ajanta Pharma Limited 기본 사항 요약
| AJANTPHARM 기본 통계 | |
|---|---|
| 시가총액 | ₹372.73b |
| 수익(TTM) | ₹8.75b |
| 수익(TTM) | ₹44.91b |
42.6x
P/E 비율8.3x
P/S 비율AJANTPHARM 주가가 과대평가되어 있나요?
공정 가치 및 가치 분석 보기수익 및 수익
| AJANTPHARM 손익 계산서(TTM) | |
|---|---|
| 수익 | ₹44.91b |
| 수익 비용 | ₹11.43b |
| 총 이익 | ₹33.48b |
| 기타 비용 | ₹24.73b |
| 수익 | ₹8.75b |
최근 보고된 수익
Sep 30, 2024
다음 수익 날짜
n/a
| 주당 순이익(EPS) | 70.06 |
| 총 마진 | 74.56% |
| 순이익 마진 | 19.48% |
| 부채/자본 비율 | 0.07% |
AJANTPHARM 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기| Ajanta Pharma 배당 날짜 | |
|---|---|
| 전 배당일 | Nov 06 2024 |
| 배당금 지급일 | Nov 27 2024 |
| 전 배당금까지의 일수 | 1 day |
| 배당금 지급일까지의 일수 | 22 days |
AJANTPHARM 신뢰할 수 있는 배당금을 지급하나요?
AJANTPHARM 배당 내역 및 벤치마크 참조